McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Technology analyst Beth Kindig believes Nvidia will be worth $10 trillion by 2030. One of Wall Street's most accurate ...

Activists display a 10 metre long climate invoice directed at developed countries at a protest during the United Nations Climate Change Conference (COP29), in Baku, Azerbaijan November 14, 2024 ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

Former Democratic congresswoman Tulsi Gabbard has been appointed as the director of national intelligence by US President-elect Donald Trump. Gabbard, who switched to the Republican Party, is a ...

Mom of 3 was brutally tortured before being set ablaze in Manipur: Autopsy A horrifying incident in Manipur's Jiribam district has left the community reeling after a 31-year-old mother of three ...

Jury deliberations began on Friday, Nov. 8, and concluded Tuesday afternoon. Following a six-week trial, the jury decided drug distributors McKesson and AmerisourceBergen would split the $266 million ...

December S&P 500 E-Mini futures (ESZ24) are trending up +2.24% this morning after Republican Donald Trump won the U.S. presidential election. Donald Trump was elected the 47th president of the United ...